Ridgeline Discovery Revenue and Competitors
Estimated Revenue & Valuation
- Ridgeline Discovery's estimated annual revenue is currently $14.7M per year.
- Ridgeline Discovery's estimated revenue per employee is $155,000
Employee Data
- Ridgeline Discovery has 95 Employees.
- Ridgeline Discovery grew their employee count by 42% last year.
Ridgeline Discovery's People
Name | Title | Email/Phone |
---|
Ridgeline Discovery Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.9M | 96 | 16% | N/A | N/A |
#2 | $75.3M | 486 | 21% | N/A | N/A |
#3 | $10.9M | 70 | 6% | N/A | N/A |
#4 | $17.4M | 112 | 37% | N/A | N/A |
#5 | $14.7M | 95 | 42% | N/A | N/A |
#6 | $10.9M | 70 | -10% | N/A | N/A |
What Is Ridgeline Discovery?
Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >50 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.
keywords:N/AN/A
Total Funding
95
Number of Employees
$14.7M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $29.9M | 96 | 5% | N/A |
#2 | $53.9M | 102 | 7% | N/A |
#3 | $23.2M | 102 | 21% | N/A |
#4 | $15.5M | 107 | -4% | N/A |
#5 | $11M | 108 | -7% | N/A |